Chiesi Pharmaceuticals B.V.
Chiesi is an international company originated in Parma, with more than 80 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.
We are the largest global pharmaceutical Group to be awarded B Corp Certification, a recognition of high social and environmental standards. We want to use business as a force for good and create a positive impact on people, environment and community.
Chiesi the Netherlands was established in 2007. We have since grown to become a reputable player in the Dutch pharmaceutical industry.
This evolution is driven by three key factors: the introduction of innovative medicines from our own pipeline, the development of existing medicines, and a successful acquisition and licensing strategy. Chiesi the Netherlands has an extensive product portfolio and focuses on six areas: asthma, COPD, CF, neonatology, transplantation and rare diseases. Our entrepreneurial and flexible approach is a key success factor for Chiesi the Netherlands and is highly valued by our customers.